Searchable abstracts of presentations at key conferences in endocrinology

ea0003p171 | Growth and Development | BES2002

Accelerated aortic root dilatation in Turner syndrome

Ostberg J

The higher risk of cardiovascular mortality in women with Turner Syndrome (TS) is partly related to their risk of aortic dissection, which causes death in 1: 50 women. Establishing factors which predict increased risk of aortic dissection is therefore of prime importance. Previous studies have suggested that multiple risk factors exist, notably coarctation, aortic root dilatation, bicuspid aortic valve and systemic hypertension.In this study we focused ...

ea0044p221 | Reproduction | SFEBES2016

Turner’s syndrome and liver involvement: prevalence and characterisation of a large population with Turner’s syndrome

Calanchini Matilde

Aims: Elevated liver function tests (↑LFTs) are frequent in Turner’s Syndrome (TS). The cause and clinical significance are unclear. The aim of this study was to analyse the association between ↑LFTs and a comprehensive panel of TS-related conditions, focusing on metabolic and cardiovascular diseases in order to further elucidate the pathophysiological mechanisms underlying this condition.Methods: We reviewed our adult TS cohort. LFTs we...

ea0059p101 | Diabetes & cardiovascular | SFEBES2018

Characterisation of diabetes mellitus in turner syndrome – Turner syndrome life course project

Pimblett Antoinette Cameron , Nair Sasha , La Rosa Clementina , Davies Melanie C , Conway Gerard S

Introduction: Diabetes Mellitus (DM) is 2–4 times more common in Turner Syndrome (TS) than karyotype normal females. Diagnosis of DM in TS is usually based on age of presentation and insulin dependency without regard for DM- autoimmunity. Previous research has identified DM associations with the isochromosome and ring chromosome. However, only small numbers of diabetics have been included in reports so far. Here we present preliminary data on DM characterisation in TS.</p...

ea0051p052 | Pituitary and growth | BSPED2017

IGF-1 titration of GH in Turner syndrome

Iyer Dhaara , Barrett Tim , Dias Renuka , Kershaw Melanie , Krone Ruth , Shaw Nick , Kirk Jeremy

Introduction: The pathogenesis of short stature and growth failure in Turner syndrome (TS) is multifactorial, and includes low birthweight, ovarian failure and skeletal dysplasia. Although abnormalities of the GH-IGF1 axis are implicated, patients are not GH-deficient (GHD) and consequently non-GHD doses of GH are utilised ie. 45–50 μg/kg per day or 9.8 mg/m2 per week. Although initially used in GHD patients, IGF1 titration is increasingly being used in al...

ea0081rc12.6 | Rapid Communications 12: Reproductive and Developmental Endocrinology | ECE2022

Is Turner syndrome at risk for thyroid carcinoma?

Belardinelli Elisabetta , Dionese Paola , Cecchetti Carolina , Vicennati Valentina , Repaci Andrea , Pagotto Uberto , Gambineri Alessandra

Background: Many questions concerning Turner Syndrome (TS) remain unresolved, such as the long-term complications and, therefore, the optimal care setting for adults. Most controversials regard tumors. Very few data are available on thyroid carcinoma and no specific screening protocol of monitoring is advised in the current official guidelines. This long-term cohort study was primarily aimed at estimating the incidence and time to comorbid conditions along the life course, inc...

ea0081ep1206 | Late Breaking | ECE2022

The impact of gh treatment in turner syndrome

Hrisca Anamaria , Dumitru Teodora , Andrei Diana , Florescu Alexandru , Leustean Letitia , Rusu Cristina , Preda Cristina , Ungureanu Maria Christina

Introduction: The treatment with growth hormone (GH) plays an essential role in the Turner syndrome (TS) management. This study evaluated its efficacy in improving adult height (AH) and metabolic parameters.Material and methods: We retrospectively analysed auxological, biochemical, genetic and pharmacological parameters of 56 girls with confirmed TS. They were categorised according to their karyotype as X monosomy (62%), isochromosome (17%), X mosaicism ...

ea0049gs1.4 | Guided session 1 | ECE2017

Cardiovascular health issues in turner syndrome

Backeljauw Philippe

Individuals with Turner syndrome (TS) have an increased risk for congenital and acquired cardiovascular disease (23–50%). This results in increased morbidity and mortality throughout the TS lifespan. There is an increased prevalence of bicuspid aortic valve malformation, coarctatio of the aorta, elongation of the transverse aortic arch, and partial anomalous venous return. In addition, TS females may develop aortopathy that may result in clinically significant aortic dila...

ea0037ep175 | Reproduction, endocrine disruptors and signalling | ECE2015

Endocrine disorders in women with Turner syndrome

Zwolak Agnieszka , Dabrowska Anna , Tarach Jerzy

Introduction: Turner syndrome (TS) is the most common chromosomal abnormality in women. It occurs in 1/2500 to 1/3000 live-born females and results from a total or partial absence of the X chromosome. The clinical manifestations are diverse and TS is accompanied by multiple medical problems.Methods: We analysed retrospectively six cases of women with TS aged 20–66 years, treated at Endocrinology Department between 2003 and 2014, to describe endocrin...

ea0030p43 | (1) | BSPED2012

Prevalence and diagnosis of cholesteatoma in Turner syndrome

Lim David , Gault Emma Jane , Kubba Haytham , Morrissey Simon , Donaldson Malcolm

Background: Cholesteatoma, a serious suppurative middle ear condition, has an increased prevalence in Turner syndrome (TS).Aims: To estimate its incidence in our TS population; identify risk factors; highlight distinctive operative findings; and suggest strategies for earlier detection.Methods: Retrospective casenote review for patients attending a TS clinic to identify those with cholesteatoma; each age-matched with three unaffect...

ea0056gp171 | Paediatrics, Developmental ' Female Reproduction | ECE2018

Autoimmunity markers in turner syndrome patients

Gawlik Aneta , Berdej-Szczot Elzbieta , Blaszczyk Ewa , Hankus Magdalena , Gawlik Tomasz , Malecka-Tendera Ewa

Background: Turner syndrome (TS) predisposes to autoimmune diseases such as thyroiditis, coeliac disease, diabetes mellitus type 1, inflammatory bowel diseases, alopecia and vitiligo. The prevalence of autoimmunity increases with age and more than one autoimmune disease can coexist together in one patient. The possible factors leading increased autoimmunity in TS are not clear.Aim: To compare the panel of autoimmunity markers in 37 TS girls (40.5% with 4...